Lakefront Biotherapeutics NV(DE:GXE)
€30.14-0.86 (-2.77%)
DE:GXE
Lakefront Biotherapeutics NV earnings date
€30.14
At close:-0.86 (-2.77%)
Lakefront Biotherapeutics NV (GXE) Q2 2024 Earnings Report
6 Followers
DE:GXE Q2 2024 EPS Results
- Actual EPS
- EUR 0.07
- Consensus EPS
- -EUR 0.07
- Beat/Miss
- Beat by +EUR 0.14
- One Year Ago EPS
- EUR 0.08
DE:GXE Q2 2024 Revenue Results
- Actual Revenue
- EUR 77.87M
- Expected Revenue
- EUR 64.07M
- Beat/Miss
- Beat by +EUR 13.80M
- YoY Revenue Growth
- -48.07%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
DE:GXE Upcoming Earnings
Lakefront Biotherapeutics NV's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GXE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | -0.66- | 11.87 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | -0.33-0.04 | -3.07 | 98.70% (+3.03) | |
| Aug 10, 2026 | 2026 (Q2) | -0.700.03 | -1.58 | 101.90% (+1.61) | |
| May 06, 2026 | 2026 (Q1) | -0.810.21 | -2.35 | 108.94% (+2.56) | |
| Feb 23, 2026 | 2025 (Q4) | ―11.87 | 0.29 | 4007.27% (+11.58) | |
| Nov 05, 2025 | 2025 (Q3) | -0.41-3.07 | -0.74 | -314.86% (-2.33) | |
| Jul 23, 2025 | 2025 (Q2) | -0.20-1.58 | 0.07 | -2357.14% (-1.65) | |
| Apr 23, 2025 | 2025 (Q1) | -0.14-2.35 | 0.36 | -752.78% (-2.71) | |
| Feb 12, 2025 | 2024 (Q4) | -0.510.29 | 2.39 | -87.91% (-2.10) | |
| Oct 30, 2024 | 2024 (Q3) | -0.15-0.74 | 0.39 | -289.74% (-1.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
